Table of Contents Table of Contents
Previous Page  5 / 670 Next Page
Information
Show Menu
Previous Page 5 / 670 Next Page
Page Background

‹ $2$& ,17(51$7,21$/

5 System Suitability Tests and/or Analytical Quality Control

6XLWDEOH PHWKRGV ZLOO LQFOXGH EODQN FKHFN VDPSOHV DQG FKHFN

VWDQGDUGV DW WKH ORZHVW SRLQW DQG PLGUDQJH SRLQW RI WKH DQDO\WLFDO

UDQJH

6 Reference Material(s)

1,67 6WDQGDUG 5HIHUHQFH 0DWHULDOŠ D ,QIDQW $GXOW

1XWULWLRQDO )RUPXOD RU HTXLYDOHQW 650 D LV D PLON EDVHG

K\EULG LQIDQW DGXOW QXWULWLRQDO SRZGHU 2QH XQLW RI 650 D

FRQWDLQV SDFNHWV HDFK FRQWDLQLQJ DSSUR[LPDWHO\ J RI PDWHULDO

7KH 650 D FHUWL¿FDWH YDOXHV IRU DPLQR DFLGV DQG WDXULQH DUH

UHIHUHQFH YDOXHV DQG DUH IRU WRWDO FRQWHQW 7DEOH 2WKHU UHIHUHQFH

PDWHULDOV PD\ EH VSHFL¿HG

7 Validation Guidance

5HFRPPHQGHG OHYHO RI YDOLGDWLRQ

Of¿cial Methods of

Analysis

60

8 Maximum Time-to-Result

1R PD[LPXP WLPH

Approved by Stakeholder Panel on Infant Formula and Adult

Nutritionals (SPIFAN). Final Version Date: September 6, 2014.

Effective Date: November 13, 2014.

7DEOH 0HWKRG SHUIRUPDQFH UHTXLUHPHQWV

a

3DUDPHWHU

0LQLPXP DFFHSWDEOH FULWHULD

$QDO\WLFDO UDQJH

±

b

/LPLW RI TXDQWLWDWLRQ /24

”

b

5HFRYHU\

±

b

“

±

±

5HSHDWDELOLW\ 56'

U

±

a

”

±

”

±

”

5HSURGXFLELOLW\ 56'

5

±

b

”

±

”

±

”

a

&RQFHQWUDWLRQV DSSO\ WR

a

µUHDG\ WR IHHG´ OLTXLGV ³DV LV´

b

UHFRQVWLWXWHG SRZGHUV J LQWR J ZDWHU DQG

c

OLTXLG

FRQFHQWUDWHV GLOXWHG E\ ZHLJKW XVLQJ ZDWHU

b

PJ J UHFRQVWLWXWHG ¿QDO SURGXFW

7DEOH 1,67 D UHIHUHQFH YDOXHV IRU DPLQR DFLGV DQG

WDXULQH

$PLQR DFLG

9DOXH

PJ J

([SDQGHG

XQFHUWDLQW\

&RYHUDJH

IDFWRU

$ODQLQH

$UJLQLQH

$VSDUWLF DFLG

a

&\VWLQH

b

*OXWDPLF DFLG

c

*O\FLQH

+LVWLGLQH

,VROHXFLQH

/HXFLQH

/\VLQH

3KHQ\ODODQLQH

3UROLQH

6HULQH

7DXULQH

7KUHRQLQH

7U\SWRSKDQ

7\URVLQH

9DOLQH

a

6XP RI $VS $VQ

b

6XP RI &66& DQG &\V

c

6XP RI *OX *OQ